Parallel Advisors LLC Purchases 196 Shares of Baxter International Inc (NYSE:BAX)

Parallel Advisors LLC increased its holdings in Baxter International Inc (NYSE:BAX) by 2.9% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,994 shares of the medical instruments supplier’s stock after acquiring an additional 196 shares during the quarter. Parallel Advisors LLC’s holdings in Baxter International were worth $612,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Pensionfund DSM Netherlands acquired a new stake in Baxter International in the second quarter worth $2,948,000. Pensionfund Sabic acquired a new stake in Baxter International in the second quarter worth $1,966,000. Beese Fulmer Investment Management Inc. raised its holdings in Baxter International by 0.3% in the second quarter. Beese Fulmer Investment Management Inc. now owns 66,471 shares of the medical instruments supplier’s stock worth $5,444,000 after purchasing an additional 193 shares during the period. WINTON GROUP Ltd raised its holdings in Baxter International by 293.0% in the second quarter. WINTON GROUP Ltd now owns 24,928 shares of the medical instruments supplier’s stock worth $2,042,000 after purchasing an additional 18,585 shares during the period. Finally, Carroll Financial Associates Inc. raised its holdings in Baxter International by 4.3% in the second quarter. Carroll Financial Associates Inc. now owns 4,418 shares of the medical instruments supplier’s stock worth $361,000 after purchasing an additional 183 shares during the period. 83.45% of the stock is owned by institutional investors.

Several research firms have weighed in on BAX. Piper Jaffray Companies reiterated a “buy” rating on shares of Baxter International in a report on Tuesday, September 10th. UBS Group cut their target price on shares of Baxter International from $98.00 to $95.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Royal Bank of Canada set a $87.00 target price on shares of Baxter International and gave the stock a “hold” rating in a report on Friday, July 26th. Barclays set a $82.00 target price on shares of Baxter International and gave the stock a “hold” rating in a report on Friday, July 26th. Finally, Credit Suisse Group increased their target price on shares of Baxter International from $84.00 to $95.00 and gave the stock an “outperform” rating in a report on Friday, July 26th. Five equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $90.14.

In related news, SVP Andrew Frye sold 3,332 shares of the firm’s stock in a transaction on Monday, October 14th. The shares were sold at an average price of $88.00, for a total value of $293,216.00. Following the completion of the transaction, the senior vice president now owns 16,391 shares of the company’s stock, valued at $1,442,408. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Jacqueline Kunzler sold 5,934 shares of the firm’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $88.12, for a total transaction of $522,904.08. Following the completion of the transaction, the senior vice president now directly owns 3,089 shares of the company’s stock, valued at approximately $272,202.68. The disclosure for this sale can be found here. Insiders have sold 17,396 shares of company stock valued at $1,528,575 in the last three months. 0.70% of the stock is owned by insiders.

Shares of BAX stock traded up $0.48 during trading hours on Friday, hitting $78.48. 811,403 shares of the company were exchanged, compared to its average volume of 3,586,525. The business has a 50 day moving average of $84.27 and a two-hundred day moving average of $82.09. The company has a current ratio of 2.78, a quick ratio of 2.10 and a debt-to-equity ratio of 0.72. Baxter International Inc has a 52 week low of $61.40 and a 52 week high of $89.93. The company has a market capitalization of $39.56 billion, a PE ratio of 25.73, a PEG ratio of 2.00 and a beta of 0.97.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.

Recommended Story: Elliott Wave Theory

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc (NYSE:BAX).

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.